Tissue regeneration

Straumann^® Emdogain supports the predictable regeneration of lost periodontal hard and soft tissue.

Straumann Emdogain is an easy-to-apply, protein-based gel that is designed to promote predictable regeneration of lost periodontal hard and soft tissues caused by periodontitis, helping to save and preserve the tooth.¹   Easy to apply with prefilled syringes, it is convenient to use and easily integrated into periodontal surgery.

Clinical Benefits

• Demonstrated safe and effective in stimulating the formation of new periodontal attachment (periodontal ligament, cementum and alveolar bone)
• More than 400 clinical publications demonstrating predictable results, including results up to 10 years ^2,3
• More than 1 million patients treated worldwide*
• Familiar surgical procedure and easy application of material to the surgical site

Practice Benefits

• Creates new treatment opportunities and revenue stream
• Creates value to your GPs and your patients
• Early treatment can achieve predictable⁴, long-lasting results²
• Helps position you as a clinician who offers excellent long-term options and results ^3,5

Patient Benefits

• Produces natural-looking results⁵
• Helps restore patients’ self-confidence
• Enhanced periodontal wound healing, as reported by clinicians
• Helps patients preserve their smile
• Less pain and discomfort**⁵

*Based on units sold
**Compared to CTG

"Straumann^® Emdogain stimulates the regeneration of both the hard and soft tissues of the periodontium at the same time.” 

-Dr. David Cochran

See how emdogain regenerates the periodontium

Saving teeth with Emdogain

Biological Guided Regeneration for Various Indications

Straumann Emdogain has documented clinical results in intrabony defects, recession defects, or furcation defects, either alone or with bone graft materials,** such as Straumann AlloGraft.

**Allograft, autograft, bone-derived xenograft, beta-TCP or bioactive glass.

¹ Bosshardt, D. Biological mediators and periodontal regeneration: a review of enamel matrix proteins at the cellular and molecular levels J Clin Periodontol 2008;35(Suppl. 8):87-105.
² Sculean et al. Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration. J Clin Periodontol 2008;35:817-824.
³ McGuire MK, Scheyer ET, Nunn M J Perio 2012
⁴ Miller PD. A classification of marginal tissue recession. Int J Periodontol Rest Dent. 1985;5,8-135 Parashis, AO et al. Enamel Matrix Derivative in Intrabony Defects. Prognostic Parameters of Clinical and Radiographic Treatment Outcomes. J Periodontol 2012: epub ahead of print.
⁵McGuire, MK & Nunn, M. Evaluation of human recession defects treated with coronally advanced flaps and either enamel matrix derivative or connective tissue. Part 1: Comparison of clinical parameters. J Periodontol 2003;74:1110–1125
⁶ Jepsen et al. A randomized clinical trial comparing enamel matrix derivative and membrane treatment of buccal class II furcation involvement in mandibular molars. Part I: Study design and results for primary outcomes. J Periodontol. 2004 Aug;75(8):1150-6.